Specialty Pharma Journal Specialty, Precision & Technology
DUBLIN, Ohio, April 18, 2017 /PRNewswire/ — Cardinal Health (NYSE: CAH) today announced that it has entered into a definitive agreement to acquire Medtronic’s Patient Care, Deep Vein Thrombosis and Nutritional Insufficiency businesses for $6.1 billion in cash. The purchase price does not include cash tax benefits of at least $100 …
Tag Archives: Cardinal Health
April, 2017
November, 2016
-
28 November
Cardinal Health to Acquire Lymphoseek from Navidea for up to $310 Million
DUBLIN, Ohio–(BUSINESS WIRE)–Navidea Biopharmaceuticals (NYSE MKT: NAVB) today announced that it has entered into a definitive asset purchase agreement with Cardinal Health (NYSE: CAH). Pursuant to the purchase agreement, Cardinal Health will purchase Navidea’s Lymphoseek® product for lymphatic mapping, lymph node biopsy and the diagnosis of metastatic spread to lymph …
December, 2015
-
14 December
Survey Shows Supply Chain Effectiveness Considered Among Top Priorities to Hospital Decision Makers
DUBLIN, Ohio, Dec. 14, 2015 /PRNewswire/ — Reimbursement is the biggest problem facing health systems today, followed closely by the increasingly high cost of supplies, according to a new, national survey of hospital executives commissioned by Cardinal Health. Financial issues, drug shortages and efficiency of the organization follow as the …
June, 2015
-
8 June
Cardinal Health to Acquire Generics Distributor Harvard Drug Group
Dublin, Ohio-based Cardinal Health recently announced its plans to buy generic drug distributor, The Harvard Drug Group (THDG), for $1.115 billion. Cardinal Health said that it plans to acquire THDG, a distributor of generic pharmaceuticals, over-the-counter medications and related products to retail, institutional and alternate care customers, currently owned by …
May, 2015
-
14 May
Cardinal Health Studies Affirm Importance of Patient Reported Outcomes for Improved Quality and Reduced Costs of Care
Patient-reported outcomes (PRO) can improve quality and reduce costs of care for high-cost, complex diseases, according to new clinical studies published by Cardinal Health Specialty Solutions. The company is unveiling a series of studies at the International Society of Pharmacoeconomic and Outcomes Research (ISPOR) annual meeting in Philadelphia, May 16-20, …
March, 2015
-
2 March
Cardinal Health to Buy Johnson & Johnson’s Cordis for Nearly $2 Billion
Johnson & Johnson announced that it is selling its Cordis business, which makes vascular technology, to Cardinal Health for approximately $1.94 billion. Cardinal will acquire Cordis for an aggregate value of $1.99 billion, consisting of $1.944 billion of cash proceeds plus approximately $46 million of retained net receivables. Cordis is …